Pages that link to "Q68534410"

The following pages link to Transfusion of ABO-mismatched platelets leads to early platelet refractoriness (Q68534410):

Displaying 41 items.

• Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Q24186359) (← links)
• A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Q24186913) (← links)
• Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Q24187751) (← links)
• Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation (Q24197779) (← links)
• A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440] (Q24801336) (← links)
• Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility (Q26784256) (← links)
• Transfusion medicine problems and solutions for the pediatric hematologist/oncologist (Q26851995) (← links)
• The evaluation and management of platelet refractoriness and alloimmunization (Q30305594) (← links)
• Refractoriness to platelet transfusions (Q33347819) (← links)
• Prophylactic platelet transfusions: which dose is the best dose? A review of the literature (Q33349172) (← links)
• Optimizing platelet transfusion therapy (Q33361167) (← links)
• Transfusion and the use of blood products (Q33382675) (← links)
• Platelet transfusion: products, indications, dose, threshold and efficacy (Q33384501) (← links)
• The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia (Q33400714) (← links)
• Managing of platelet transfusion refractoriness of haematological malignancies. Experience IPC-EFSAM (Q33417908) (← links)
• Effectiveness of Pooled Platelet Transfusion in Concordant and Discordant Groups among Dengue Patients (Q33435375) (← links)
• Taking a wider view on fetal/neonatal alloimmune thrombocytopenia (Q33439854) (← links)
• Ineffectiveness of platelet transfusions in the course of thrombocytopenia of central origin. Work Group coordinated by ANDEM (Q33489533) (← links)
• Therapeutic support of the patient with thrombocytopenia. (Q33490485) (← links)
• ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies (Q34089952) (← links)
• Platelet transfusions: Impact on hemostasis, thrombosis, inflammation and clinical outcomes (Q34708937) (← links)
• Efficacy and Adverse Events of Platelet Transfusion Product-Specific Differences (Q34791060) (← links)
• 2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium. (Q36068943) (← links)
• What would Karl Landsteiner do? The ABO blood group and stem cell transplantation (Q36207276) (← links)
• Platelet transfusion - the art and science of compromise (Q37049262) (← links)
• Providing ABO‐identical platelets and cryoprecipitate to (almost) all patients: approach, logistics, and associated decreases in transfusion reaction and red blood cell alloimmunization incidence (Q39719219) (← links)
• [Factors affecting posttransfusion platelet efficiency "close relationship between patient and product"]. (Q40449539) (← links)
• ABO matching of platelet transfusions - "Start Making Sense". "As we get older, and stop making sense…" - The Talking Heads (1984). (Q43207995) (← links)
• Preparation of single donor platelet with low antibody titers for all patients (Q50516261) (← links)
• The ethics of randomised controlled trials: a matter of statistical belief? (Q52306816) (← links)
• The second century of ABO: and now for something completely different. (Q53535347) (← links)
• Platelet transfusion therapy (Q71919358) (← links)
• ABO and platelet transfusion revisited (Q72799054) (← links)
• Platelet products, where to? (Q73689863) (← links)
• PLTs of Blood Group A1 donors express increased surface A antigen owing to apheresis and prolonged storage (Q79079824) (← links)
• [Transfusion support of haematological malignancies in 2012: evolution of the recommendations] (Q87413726) (← links)
• Platelet component transfusion and alloimmunization: Where do we stand? (Q87873717) (← links)
• High-Throughput Screening of Blood Donors for Twelve Human Platelet Antigen Systems Using Next-Generation Sequencing Reveals Detection of Rare Polymorphisms and Two Novel Protein-Changing Variants (Q89940351) (← links)
• Neonatal and pediatric platelet transfusions: current concepts and controversies (Q90016772) (← links)
• Transfusion medicine: A research agenda for the coming years (Q92550995) (← links)
• Effects of ABO Matching of Platelet Transfusions in Critically Ill Children (Q93034360) (← links)